Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metformin and everolimus in neuroendocrine tumours: A synergic effect?
Hue-Fontaine L, Lemelin A, Forestier J, Raverot G, Milot L, Robinson P, Borson-Chazot F, Lombard-Bohas C, Walter T. Hue-Fontaine L, et al. Among authors: lemelin a. Clin Res Hepatol Gastroenterol. 2020 Nov;44(6):954-960. doi: 10.1016/j.clinre.2020.02.011. Epub 2020 Mar 4. Clin Res Hepatol Gastroenterol. 2020. PMID: 32146090
Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Takemura K, Yuasa T, Lemelin A, Ferrier E, Wells JC, Saad E, Saliby RM, Basappa NS, Wood LA, Jude E, Pal SK, Donskov F, Beuselinck B, Szabados B, Powles T, McKay RR, Gebrael G, Agarwal N, Choueiri TK, Heng DYC. Takemura K, et al. Among authors: lemelin a. ESMO Open. 2024 Jul;9(7):103606. doi: 10.1016/j.esmoop.2024.103606. Epub 2024 Jun 19. ESMO Open. 2024. PMID: 38901174 Free PMC article.
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
Saad E, Gebrael G, Semaan K, Eid M, Saliby RM, Labaki C, Sayegh N, Wells JC, Takemura K, Ernst MS, Lemelin A, Basappa NS, Wood LA, Powles T, Ernst DS, Lalani AA, Agarwal N, Xie W, Heng DYC, Choueiri TK. Saad E, et al. Among authors: lemelin a. Oncologist. 2024 Aug 5;29(8):699-706. doi: 10.1093/oncolo/oyae072. Oncologist. 2024. PMID: 38630540 Free PMC article.
16 results